°ÄÃÅÁùºÏ²Ê¿ª½±¼Ç¼

Phishing warning 01-May-2024
We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information.

Genome Editing USA Congress 2017

10 May 2017 08:30 - 11 May 2017 17:30, Boston, United States


Introduction
Over two days our event will bring together over 200 senior level attendees from academia, research institutes and pharma companies to discuss therapeutic and drug discovery applications, as well as novel gene-editing techniques and technologies. This event provides an ideal platform to participate in formal 1-2-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field.

The conference programme will consist of 3 interactive streams covering:
  • Genome Editing Technologies
  • Drug Discovery & Development Applications
  • Therapeutic Applications of Genome Editing
Across the two-day event, our expert panel of speakers will offer a comprehensive view at critical advances in genome editing research. We will also be hosting key biotech solution providers, giving attendees the chance to hear about the very latest state-of-the-art technologies.

The event will be co-located with our Advances in Transgenic Technology Congress.

Day one features a whole session dedicated to exploring the opportunities and challenges of genome editing technologies. The afternoon will be split into interactive workshops covering key areas such as target identification and therapeutic applications.
 
On day two the technology session will move more toward the development of delivery solutions, software and bioinformatic aspects of genome editing and key regulatory issues. The morning workshops will address genome editing approaches to accelerate drug discovery.  

For more information on how to register for the meeting please contact d.dalby@oxfordglobal.co.uk

Useful links

Speakers
  • André Choulika Chief Executive Officer, Cellectis, United States
  • Rob Howes Director, AstraZeneca, United Kingdom
  • Marcello Maresca Associate Principal Scientist, AstraZeneca, Sweden
  • Danilo Maddalo Principal Scientist, Novartis, Switzerland
  • Jim Collins Professor, Massachusetts Institute of Technology, United States
  • George Church Professor, Harvard University & MIT, United States

Venue
The Joseph B. Martin Conference Center at Harvard Medical School

The Joseph B. Martin Conference Center at Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA 02115, United States

Organised by
Contact information
Search
 
 
Showing all upcoming events
Start Date
End Date
Location
Subject area
Event type

Advertisement
Spotlight


E-mail Enquiry
*
*
*
*